Skip to main content
SpringerLink
Log in

Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Schwaab J, Knut M, Haferlach C, Metzgeroth G, Horny HP, Chase A, Tapper W, Score J, Waghorn K, Naumann N, Jawhar M, Fabarius A, Hofmann WK, Cross NC, Reiter A (2015) Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes. Ann Hematol 94(2):233–8

    Article  CAS  PubMed  Google Scholar 

  2. Lierman E, Selleslag D, Smits S, Billiet J, Vandenberghe P (2012) Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/PCM1-JAK2-positive chronic eosinophilic leukemia. Blood 120(7):1529–31

    Article  CAS  PubMed  Google Scholar 

  3. Rumi E, Milosevic JD, Casetti I, Dambruoso I, Pietra D, Boveri E, Boni M, Bernasconi P, Passamonti F, Kralovics R, Cazzola M (2013) Efficacy of ruxolitinib in chronic eosinophilic leukemia associated with a PCM1-JAK2 fusion gene. J Clin Oncol 31(17):e269–71

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The study was supported by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) (Special Program “Molecular Clinical Oncology 5 per mille” AGIMM-AIRC Gruppo Italiano Malattie Mieloproliferative- project no. 1005 to MC, and my first AIRC grant MFAG project 15672 to ER) and by a grant form Italian Ministry of Health (GR-2010-2312855) to ER. A special thank to Dr. Laura Tassi and Prof. Giorgio Lo Russo for their technical support.

Conflict of interest

The authors do not have potential conflicts of interest related to this paper.

Author information

Authors and Affiliations

  1. Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo, Viale Golgi 19, 27100, Pavia, Italy

    Elisa Rumi, Daniela Pietra, Chiara Milanesi, Irene Dambruoso, Cesare Astori & Mario Cazzola

  2. CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria

    Jelena D. Milosevic & Robert Kralovics

  3. AZ Sint-Jan, Brugge, Belgium

    Dominik Selleslag

  4. Department of Molecular Medicine, University of Pavia, Pavia, Italy

    Ilaria Casetti, Chiara Cavalloni, Marta Bellini & Mario Cazzola

  5. Center for Human Genetics, KU Leuven/University Hospital Leuven, Leuven, Belgium

    Els Lierman & Peter Vandenberghe

  6. Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria

    Robert Kralovics

Authors
  1. Elisa Rumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jelena D. Milosevic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dominik Selleslag
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ilaria Casetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Els Lierman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Daniela Pietra
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chiara Cavalloni
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marta Bellini
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Chiara Milanesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Irene Dambruoso
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Cesare Astori
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Robert Kralovics
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Peter Vandenberghe
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Mario Cazzola
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elisa Rumi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rumi, E., Milosevic, J.D., Selleslag, D. et al. Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene. Ann Hematol 94, 1927–1928 (2015). https://doi.org/10.1007/s00277-015-2451-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2451-7

Keywords

Search

Navigation